Lipids and adipokines as risk factors for Alzheimer's disease

Matthew W. Warren, Linda S. Hynan, Myron F. Weiner, Rachelle Doody, Susan Rountree, Violeta Capriles, Christie Ballantyne, Eveleen Darby, Tracy Dawson, Aline Hittle, Aisha Khaleeg, Sid O'Bryant, Paula Grammas, Benjamin Williams, Chuang Kuo Wu, Yan Zhang, Gregory Schrimsher, Andrew Dentino, Parastoo Momeni, Larry HillThomas Fairchild, Janice Knebl, Robert Barber, Douglas Mains, Lisa Alvarez, Perrie Adams, Roger Rosenberg, Joan Reisch, Ryan Huebinger, Doris Svetlik, Janet Smith Mechelle Murray, Tomequa Sears, Donald Royall, Helen Hazuda, Raymond Palmer, Marsha Polk

Producción científica: Articlerevisión exhaustiva

74 Citas (Scopus)


To determine if measures of adipokines and other blood lipids differentiate between normal controls and persons with Alzheimer's disease (AD), we examined levels of leptin, adiponectin, total cholesterol, high density lipoproteins (HDL), calculated low density lipoproteins (LDL), triglycerides and apolipoprotein E allele status in 148 early AD subjects and 198 normal controls. We were unable to demonstrate a significant difference between leptin and adiponectin levels between normal controls and AD subjects. We were able to confirm observations of lower HDL and higher total and LDL cholesterol concentration in AD subjects than in controls. As expected, the presence of the apolipoprotein E4 allele distinguished between the two groups.

Idioma originalEnglish (US)
Páginas (desde-hasta)151-157
Número de páginas7
PublicaciónJournal of Alzheimer's Disease
EstadoPublished - 2012

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Psychiatry and Mental health
  • Clinical Psychology
  • General Neuroscience


Profundice en los temas de investigación de 'Lipids and adipokines as risk factors for Alzheimer's disease'. En conjunto forman una huella única.

Citar esto